Experienced in Hyperaldosteronism

Wanlong H. Tan

17 Hongqi Avenue, 
Ganzhou, CN 
Experienced in Hyperaldosteronism
17 Hongqi Avenue, 
Ganzhou, CN 
OverviewLocationsClinical Research

Overview

Wanlong Tan practices in Ganzhou, China. Tan is rated as an Experienced expert by MediFind in the treatment of Hyperaldosteronism. Their top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Interstitial Nephritis, Lithotripsy, and Ureteroscopy.

Their clinical research consists of co-authoring 99 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hyperaldosteronism.

Locations

17 Hongqi Avenue, Ganzhou, 341000, China
Other Locations
No. 1838, North Of Guangzhou Avenue, Guangzhou, 510515, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3

99 Total Publications

Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma.
Developing and experimentally validating a glucocorticoid signaling-related gene signature to evaluate the prognosis and immunotherapeutic response in kidney renal clear cell carcinoma.
Journal: PloS one
Published: June 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tan's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile